In Talking Precision Medicine podcast we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. 

Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. 

Today we speak with Luba Greenwood, who works in Strategic Business Development and Corporate Ventures at Verily, an Alphabet company. 

Luba brings to Google her experience in pharmaceutical, biotechnology, and digital health industries. Not to mention her expertise in building and investing in innovative technology companies. 

She is on the Board of MassBio and Brooklyn ImmunoTherapeutics, and serves as an Advisor to the Dana Farber Cancer Institute.

In this episode, we dive into Luba’s work across the intersections of healthcare and technology.